Wyeth Pakistan Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wyeth Pakistan Limited with three other
pharmaceutical manufacturers in Asia:
UBI Pharma Inc
sales of 357.74 million Taiwanese Dollars [US$11.79 million]
of which 100%
was Single Segment),
Coral Laboratories Limited
(770.16 million Indian Rupees [US$11.96 million]
Parabolic Drugs Limited
based in India
(768.35 million Indian Rupees [US$11.93 million]
During the year ended November of 2016, sales at
Wyeth Pakistan Limited were 1.25 billion Pakistan Rupees (US$11.90 million).
decrease of 53.2%
versus 2015, when the company's sales were 2.67 billion Pakistan Rupees.